Vigilant Biosciences Closes $5.5 Million Series B Round of Funding February 24, 2015 MIAMI, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today the successful completion of a $5.5 million Series B round of funding, bringing the total amount of
Miami Life Science Startup Stems from Personal Mission to Fight Oral Cancer February 24, 2015 Matthew H.J. Kim, a patent attorney by training, was heart-broken by the suffering and aggressive treatment his mother went through with oral cancer. He also saw first-hand the results of what he calls an inadequate standard of care resulting in
Miami Startup Raises $5.5M for Cancer Risk Detection System February 24, 2015 Miami-based Vigilant Biosciences raised $5.5 million to launch its oral cancer risk detection system, the firm announced Tuesday. Investors included White Owl Capital Partners, venVelo and the Florida Institute for the Commercialization of Public Research. The company has raised $7.8 million to date.